<?xml version="1.0" encoding="UTF-8"?>
<communities type="array">
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:35+00:00</created-at>
    <description>&lt;p&gt;Naegeli&#8211;Franceschetti&#8211;Jadassohn Syndrome is a rare form of ectodermal dysplasia characterized by reticular skin pigmentation, diminished function of the sweat glands, the absence of teeth and the thickening of the skin of the palms and soles.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Naegeli&#8211;Franceschetti&#8211;Jadassohn Syndrome is a rare form of ectodermal dysplasia characterized by reticular skin pigmentation, diminished function of the sweat glands, the absence of teeth and the thickening of the skin of the palms and soles.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1036</id>
    <name>Naegeli-Franceschetti-Jadassohn Syndrome</name>
    <participations-count type="integer">0</participations-count>
    <permalink>naegeli-franceschetti-jadassohn-syndrome</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">0.04</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Chromatophore nevus of Naegeli, Naegeli Franceschetti Jadassohn syndrome, Subset of ectodermal dysplasia</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2010-02-10T21:20:56+00:00</updated-at>
  </community>
  <community>
    <causes>&lt;p&gt;Genetic mutation of the gene LMX1B on chromosome 9q34&lt;/p&gt;</causes>
    <created-at type="datetime">2008-05-21T13:25:34+00:00</created-at>
    <description>&lt;p&gt;Nail-Patella Syndrome is a rare genetic disorder characterized by hypoplastic or absent patellae, dystrophic nails, dysplasia of the elbows, iliac horns, clubbed feet, glaucoma and kidney disease.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Nail-Patella Syndrome is a rare genetic disorder characterized by hypoplastic or absent patellae, dystrophic nails, dysplasia of the elbows, iliac horns, clubbed feet, glaucoma and kidney disease.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">808</id>
    <name>Nail-Patella Syndrome</name>
    <participations-count type="integer">3</participations-count>
    <permalink>nail-patella-syndrome</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">2.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Iliac Horn Syndrome, Hereditary Onychoostedysplasia, Fong Disease, Turner-Kiser Syndrome, Nail Patella Syndrome, NPS, HOOD</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2008-12-10T22:47:17+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:32+00:00</created-at>
    <description>&lt;p&gt;Narcolepsy is a neurological condition most characterized by Excessive Daytime Sleepiness.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Narcolepsy is a neurological condition most characterized by Excessive Daytime Sleepiness.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">525</id>
    <name>Narcolepsy</name>
    <participations-count type="integer">1</participations-count>
    <permalink>narcolepsy</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">49.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Irresistible Sleepiness, Cataplexy, Onset of Sleep in Desynchronized Phase, Narcolepsy-Cataplexy, Gelineau Disease</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-01-12T23:02:23+00:00</updated-at>
  </community>
  <community>
    <causes nil="true"></causes>
    <created-at type="datetime">2008-05-21T13:25:33+00:00</created-at>
    <description nil="true"></description>
    <diagnosis nil="true"></diagnosis>
    <disorder-description nil="true"></disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms nil="true"></general-symptoms>
    <general-test nil="true"></general-test>
    <general-treatment nil="true"></general-treatment>
    <id type="integer">650</id>
    <name>NARP syndrome</name>
    <participations-count type="integer">0</participations-count>
    <permalink>narp-syndrome</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">8.5</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis nil="true"></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags nil="true"></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2008-05-21T13:25:33+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:34+00:00</created-at>
    <description>&lt;p&gt;Nemaline Myopathy is a rare neuromuscular disorder.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Nemaline Myopathy is a rare neuromuscular disorder.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">879</id>
    <name>Nemaline Myopathy</name>
    <participations-count type="integer">0</participations-count>
    <permalink>nemaline-myopathy</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">1.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>rod myopathy, nemaline rod myopathy</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2009-06-12T18:27:00+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:35+00:00</created-at>
    <description>&lt;p&gt;Neonatal Diabetes Mellitus is a genetic form of diabetes resulting in the congenital impairment of insulin release.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Neonatal Diabetes Mellitus is a genetic form of diabetes resulting in the congenital impairment of insulin release.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">976</id>
    <name>Neonatal Diabetes Mellitus</name>
    <participations-count type="integer">1</participations-count>
    <permalink>neonatal-diabetes-mellitus</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">0.2</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Permanent neonatal diabetes mellitus</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-10-06T14:06:57+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-12-18T19:43:04+00:00</created-at>
    <description>&lt;p&gt;Neonatal Onset Multisystem Inflammatory Disease is a rare genetic disorder which causes inflammation in multiple parts of the body.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Neonatal Onset Multisystem Inflammatory Disease is a rare genetic disorder which causes inflammation in multiple parts of the body.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1275</id>
    <name>Neonatal Onset Multisystem Inflammatory Disease</name>
    <participations-count type="integer">6</participations-count>
    <permalink>neonatal-onset-multisystem-inflammatory-disease</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">100.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net/data/patho/Pro/en/CINCA-FRenPro3395.pdf</prevalence-number-source-url>
    <prevalence-type>Cases</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>NOMID, Chronic Neurologic Cutaneous and Articular Syndrome, CINCA, Cryopyrin-Associated Periodic Syndromes, CAPS, Chronic Infantile Neurological, Cutaneous and Articular Syndrome</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-02-08T06:55:03+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:34+00:00</created-at>
    <description>&lt;p&gt;Diabetes insipidus is a disorder characterized by excretion of large amounts of diluted urine.  Nephrogenic diabetes insipidus is cuased by the kidney&amp;#8217;s inabilityto respond normally to &lt;span class="caps"&gt;ADH&lt;/span&gt;.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Diabetes insipidus is a disorder characterized by excretion of large amounts of diluted urine.  Nephrogenic diabetes insipidus is cuased by the kidney&amp;#8217;s inabilityto respond normally to &lt;span class="caps"&gt;ADH&lt;/span&gt;.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">923</id>
    <name>Nephrogenic diabetes insipidus</name>
    <participations-count type="integer">2</participations-count>
    <permalink>nephrogenic-diabetes-insipidus</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">0.5</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-08-02T20:17:37+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2009-03-23T15:34:31+00:00</created-at>
    <description>&lt;p&gt;Nephrogenic Systemic Fibrosis is a rare disorder involving fibrosis of skin, joints, eyes, and internal organs.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Nephrogenic Systemic Fibrosis is a rare disorder involving fibrosis of skin, joints, eyes, and internal organs.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1372</id>
    <name>Nephrogenic Systemic Fibrosis</name>
    <participations-count type="integer">0</participations-count>
    <permalink>nephrogenic-systemic-fibrosis</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>NSF, Nephrogenic fibrosing dermopathy</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-03-23T15:34:31+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-11-07T15:46:35+00:00</created-at>
    <description>&lt;p&gt;Nerve Entrapment is a disorder that occurs when nerves become compressed or entrapped at various regions of the extremities.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Nerve Entrapment is a disorder that occurs when nerves become compressed or entrapped at various regions of the extremities.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1241</id>
    <name>Nerve Entrapment</name>
    <participations-count type="integer">1</participations-count>
    <permalink>nerve-entrapment</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>carpal tunnel syndrome, cubital tunnel, Guyon canal, meralgia paresthetica, Tarsal tunnel syndrome, 
</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-11-07T15:46:35+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:34+00:00</created-at>
    <description></description>
    <diagnosis></diagnosis>
    <disorder-description></disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">841</id>
    <name>Netherton Syndrome</name>
    <participations-count type="integer">0</participations-count>
    <permalink>netherton-syndrome</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">1.35</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Netherton disease</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-09-24T13:08:48+00:00</updated-at>
  </community>
  <community>
    <causes nil="true"></causes>
    <created-at type="datetime">2008-05-21T13:25:33+00:00</created-at>
    <description nil="true"></description>
    <diagnosis nil="true"></diagnosis>
    <disorder-description nil="true"></disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms nil="true"></general-symptoms>
    <general-test nil="true"></general-test>
    <general-treatment nil="true"></general-treatment>
    <id type="integer">636</id>
    <name>Neuroblastoma</name>
    <participations-count type="integer">3</participations-count>
    <permalink>neuroblastoma</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">10.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis nil="true"></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags nil="true"></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2009-07-03T03:07:41+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:32+00:00</created-at>
    <description>&lt;p&gt;Neurofibromatosis Type 1 is a rare inherited disease characterized by neurologic and dermatologic lesions.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Neurofibromatosis Type 1 is a rare inherited disease characterized by neurologic and dermatologic lesions.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">560</id>
    <name>Neurofibromatosis Type 1</name>
    <participations-count type="integer">7</participations-count>
    <permalink>neurofibromatosis-type-1</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">25.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>von Recklinghausen Syndrome, Neurofibromatosis Type I, NF I</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-09-12T16:57:35+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:34+00:00</created-at>
    <description>&lt;p&gt;Neurofibromatosis Type 2 is rare inherited genetic disorder characterized by non-malignant brain tumours in the vestibulocochlear nerve.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Neurofibromatosis Type 2 is rare inherited genetic disorder characterized by non-malignant brain tumours in the vestibulocochlear nerve.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">924</id>
    <name>Neurofibromatosis Type 2</name>
    <participations-count type="integer">3</participations-count>
    <permalink>neurofibromatosis-type-2</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">0.5</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>MISME Syndrome, Multiple Inherited Schwannomas, Meningiomas, and Ependymomas, Neurofibromatosis Type II, NF-2, NF2</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-08-31T15:40:40+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:33+00:00</created-at>
    <description>&lt;p&gt;Neuropathy Hereditary with Liability to Pressure Palsies is a disorder in which the peripheral nerves are unusually sensitive to pressure.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Neuropathy Hereditary with Liability to Pressure Palsies is a disorder in which the peripheral nerves are unusually sensitive to pressure.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">643</id>
    <name>Neuropathy Hereditary with Liability to Pressure Palsies</name>
    <participations-count type="integer">5</participations-count>
    <permalink>neuropathy-hereditary-with-liability-to-pressure-palsies</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">9.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-09-29T19:53:13+00:00</updated-at>
  </community>
</communities>
